Filing Flows › Pulse Biosciences (PLSE) › Recalls, complaints & regulation
Pulse Biosciences (PLSE): clinical trials
Pulse Biosciences (PLSE) beyond its filings: 6 active clinical trials.
Pulse Biosciences' latest quarter
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Pulse Biosciences have?
6 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.